您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[港股财报]:锦欣生殖2023中期报告 - 发现报告

锦欣生殖2023中期报告

2023-09-27港股财报M***
锦欣生殖2023中期报告

Jinxin Fertility Group Limited* (根據開曼群島法律註冊成立的有限公司) 股份代號:01951 2023中期報告 *僅供識別 23562844454749515387 ARSARS2018ARS20,958IVF3.1%2018ARSHRC FertilityHRC ManagementHRC Medical2018ARSARS ARS2021IVF2023ARSARS 20217ARS20212023ARSARSARS John G. Wilcox John G. Wilcox John G. Wilcox Cricket Square, Hutchins DriveP.O. Box 2681, Grand CaymanKY1-1111Cayman Islands 301 131 John G. Wilcox 32023 ConyersTrust Company(Cayman)LimitedCricket Square, Hutchins DriveP.O. Box 2681, Grand CaymanKY1-1111Cayman Islands 183171712–1716 826 •8835 1951 www.jxr-fertility.com 2023COVID-192023 ARS 202111ARSIVF202212 20234ARS2023ARSPGT ARSIVF IVF ARS5(i)IVF(ii)35(iii)35(iv)(PCOS)(v)IVFIVF 2022202392.9%2.9%95.8%ARS ARS202323111202216% 202111ARS ARSIVF202212202312023437GCP 20237PGTIUI(AIHAID)IVF-EFICSIPGT2020123178PGT20237IVFIVF 2023 2023202232.7%202320228.7% ARS202222024(i)ARS(ii)(iii) 2023630SCI100 20212023202276%202316%16% 2022831IVFARS2023152% 2022796.50% 2023IVF202239% HRCCOVID-192023202221% HRC ManagementUSCUSC FertilityUSC Fertility(i) USC FertilityHRCPasadena(ii)HRCUSC(iii)HRCUSC FertilityIVFIVF HRC Medical23HRCMedical 2023ARS30%ARSARS 20217(2015-2020)20228 ARSARS IVFARS ARS 2022252024(i)ARS(ii)(iii) 2022796.50% IVFARS 202342023120234GCPIIIII20237PGTIUI(AIHAID)IVF-EFICSIPGT20237IVFIVF2023 ARS HRCMedical46HRC Medical ARS2020320238 20221 2022ARSIVF 2023SCI2019 20221USC Keck School of MedicineIVFIVF 2023(i)(ii)(iii) HRCUSC Keck Schoolof Medicine 202222022(i)(ii)(iii)2023118202265,853,241202257,170,2472022 HRCManagementUSCHRC ManagementUSC (i)(ii)202312 2023(EMR) (HSCRM)HSCRM20HSCRMHSCRM ESG ESGESG2023 20226301,138.217.2%20236301,333.9(i)(ii)20227 (i)ARS(ii)(iii)(iv)(v) 2022630701.52.0%2023630687.4(i)(ii) ARS2022630420.71.8%2023630413.3IVF(i)2023IVF(ii)20227 2022630280.82.4%2023630274.0 2022630165.613.8%2023630188.4(i)IVF(ii)IVF 20226306.6152.0%202363016.62022831ARS 2022796.50%2023630122.6 202263026.216.1%202363030.5IVF 2022630238.321.0%2023630288.4(i)IVF(ii)HRCIVF 2022630673.914.2%2023630769.6(i)(ii)20227 2022630464.321.5%2023630564.3(i)(ii)20227202263040.8%202363042.3%(i)(ii)20228ARS(iii) 202263027.473.3%202363047.5 202363010.5 20226304.7124.8%202363010.6 (ii) 202263053.762.5%202363087.2 2022630187.60.25%2023630188.1 202263033.029.3%202363042.730020223 202263046.118.8%202363054.7 2022630202363019.7% EBITDAEBITDA 20232022630 EBITDA (2) (3)ARSARS2022831ARS 2022630187.619.3%2023630223.8202363016.8%202263016.5%2022630(i)(ii)(iii)20228ARS(iv)(i)(ii) 2022630190.117.6%2023630223.6 12022630258.21.2%2023630255.0202363019.1%202263022.7%2023630(i)(ii) 2022630260.72.3%2023630254.8 EBITDA EBITDA22022630333.516.3%2023630387.72023630EBITDA29.1%202263029.3%2023630EBITDA(i)(ii)EBITDA EBITDA32022630384.12.6%2023630394.12023630EBITDA29.5%202263033.7%2023630EBITDA(i)(ii)EBITDA 20236300.080.0820226300.080.071020236300.1020226300.10 2022123162.525.3%202363046.7 20221231188.73.1%2023630194.6 20221231916.97.9%2023630844.2 201962,808.1202121,253.472021300202232023156.725175,000,0001,162,310,000999,098,0002023116 2023630 2023630 2023630433.5 20236302,365.7202212312,089.3 2023630 2023630 2023630 100%202363023.2%2022123123.9% 20236303,0452,8302152023630366.32022630336.6 202220192152022217– D.202220222172023118202265,853,241(i)29,060,994159(ii)36,792,247510202257,170,247 201963– E.2023630 20236302022630 2023630 2023630 2023630 2023630 13.51B(1) 2,808.12023630 2023630 (1)(3)ARSARS(4)ARS(5) (1)(i)20.0%561.6(a)(b)(c)(ii)5.0%140.4(2)(3)(4)(i)Jinxin Hospital Management Group LimitedIVF(ii)Jinxin Medical Management (BVI) Group Limited(5)(i)(ii)(iii) 202122Morgan Stanley & Co. International plc80,000,00015.8515.6716.930.00001800.00202122202129 2021291,253.472021222021292023630 202315Jinxin Fertility BVI(i)6.725175,000,000(ii)175,000,0006.647.090.000011,750.002023152023116 20231920231161,162.3120231520231162023630 2023630 •2023118202265,853,241202382357,170,247 2023630XVXV78352 (i) (1)20236302,720,913,796 (ii) (1)51%2021(2)51%2019 2023630XVXV78352 18 2023630XV23336 (1)Jinxin Fertility BVI10%2023630 (2)HHLR Advisors, Ltd.HHLR Fund, L.P.HHLR Fund, L.P. 2023630XV23336 2019632023630 (1) (2) (a)(b)(c) (3) 238,081,58010%8.75%2023112023630238,081,580 (4) 121%12 (5) 1.00 28 (6) (i)(ii) (7) 25 (8) (i)(ii)(iii) (9) 2023630 2019215 (1) (i)(ii)(iii) (2) (3) 32,981,3881.66%1.21%1,737,6940.06% (4) (5) 15 (6) (7) 2023630 22 20231120236301,737,694 (1) (2)20221231251,665 2022 20222022217202220222022 (1)2022 2022(i)2022(ii)(iii) (2)2022 2022 (3) 202275,227,5143%2.76%2022202218,057,2670.66% (4) 2022 (5)2022 (6) 2022 (7)2022 202220236302022 2023118202265,853,2412022202311202363075,227,5149,374,273202382357,170,247 45862023630343434 2410 34 2023829 20236 30 20236 30 (i)20226302022412288,683,00086,873,00015%201,810,00070%24.44% (ii)10%50% 20236 30 1. 201853221961320182019625 (i)(ii)(iii)(iv)(